Weiss Multi-Strategy Advisers’s Aegerion Pharmaceuticals AEGR Stock Holding History

Weiss Multi-Strategy Advisers’s Portfolio AEGR Stock Details AEGR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-19,000	Closed	-$497K	–	588
2015 Q1	$497K	Sell	19,000 -1,000	-5%	-$25.4K	0.02%	366
2014 Q4	$419K	Sell	20,000 -10,000	-33%	-$252K	0.01%	351
2014 Q3	$1M	Hold	30,000	–	–	0.02%	379
2014 Q2	$963K	Buy	30,000 +280	+0.9%	+$10.4K	0.02%	423
2014 Q1	$1.37M	Buy	29,720 +16,950	+133%	+$994K	0.03%	419
2013 Q4	$906K	Buy	+12,770	New	+$977K	0.02%	461

Other funds holding AEGR

ACM

Americafirst Capital Management Roseville, California $74M AUM 13.49% 1-Year Est. Return

SCM

Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Weiss Multi-Strategy Advisers's AEGR Position: Q2 2015 in Review

Weiss Multi-Strategy Advisers sold out of Aegerion Pharmaceuticals (AEGR) in Q2 2015, closing a stake of 19,000 shares — an estimated $497K sold.

Weiss Multi-Strategy Advisers first reported a position in AEGR in Q4 2013 and held it in 6 quarters. The position peaked at $1.37M in Q1 2014. 97 funds tracked by Wall St. Rank hold AEGR as of Q2 2015.

Weiss Multi-Strategy Advisers reported no remaining Aegerion Pharmaceuticals position as of Q2 2015 after selling out during the quarter.
Weiss Multi-Strategy Advisers sold 19,000 Aegerion Pharmaceuticals shares in Q2 2015, an estimated $497K.
Weiss Multi-Strategy Advisers first reported a position in Aegerion Pharmaceuticals in Q4 2013 and held it in 6 quarters.
Weiss Multi-Strategy Advisers's Aegerion Pharmaceuticals position peaked at $1.37M in Q1 2014.
97 funds tracked by Wall St. Rank held Aegerion Pharmaceuticals as of Q2 2015.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q2 2015, filed 14 Aug 2015.